Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 121, Issue 7, Pages 545-555
Publisher
Springer Science and Business Media LLC
Online
2019-08-15
DOI
10.1038/s41416-019-0551-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 2 Study of Bortezomib Combined With Temozolomide and Regional Radiation Therapy for Upfront Treatment of Patients With Newly Diagnosed Glioblastoma Multiforme: Safety and Efficacy Assessment
- (2018) Xiao-Tang Kong et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
- (2016) Jeffrey J. Raizer et al. JOURNAL OF NEURO-ONCOLOGY
- Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma
- (2016) D. Jay McCracken et al. JOURNAL OF NEURO-ONCOLOGY
- A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
- (2015) Yazmín Odia et al. JOURNAL OF NEURO-ONCOLOGY
- p62/SQSTM1 is involved in caspase-8 associated cell death induced by proteasome inhibitor MG132 in U87MG cells
- (2014) Rui-xia Zeng et al. CELL BIOLOGY INTERNATIONAL
- mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells
- (2014) Sarah Smalley et al. Molecular Cancer
- ProteomeXchange provides globally coordinated proteomics data submission and dissemination
- (2014) Juan A Vizcaíno et al. NATURE BIOTECHNOLOGY
- Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma
- (2014) S. J. Han et al. NEURO-ONCOLOGY
- Bortezomib Downregulates MGMT Expression in T98G Glioblastoma Cells
- (2013) Panagiotis J. Vlachostergios et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner
- (2013) Panagiotis J. Vlachostergios et al. INVESTIGATIONAL NEW DRUGS
- Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis
- (2013) Daniela A. Bota et al. JOURNAL OF NEUROSURGERY
- Optimizing Glioblastoma Temozolomide Chemotherapy Employing Lentiviral-based Anti-MGMT shRNA Technology
- (2013) Thomas Viel et al. MOLECULAR THERAPY
- Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma
- (2011) Agnete Svendsen et al. ACTA NEUROPATHOLOGICA
- A phase I study of bortezomib and temozolomide in patients with advanced solid tumors
- (2011) J. Portnow et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- A reproducible brain tumour model established from human glioblastoma biopsies
- (2010) Jian Wang et al. BMC CANCER
- Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma
- (2010) Surasak Phuphanich et al. JOURNAL OF NEURO-ONCOLOGY
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
- (2009) Y. Liu et al. CANCER RESEARCH
- Phase I Trial Using Proteasome Inhibitor Bortezomib and Concurrent Temozolomide and Radiotherapy for Central Nervous System Malignancies
- (2008) Gregory J. Kubicek et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started